Restructuring 23andMe: The High-Stakes Balance Between Finance and Data Protection
Complex Discovery
MARCH 24, 2025
Editor’s Note: 23andMes Chapter 11 filing marks a pivotal moment for both the company and the wider biotechnology sector. The proceedings come with a commitment to debtor-in-possession (DIP) financing to the tune of $35 million, courtesy of JMB Capital Partners.
Let's personalize your content